home / stock / xrtx / xrtx quote
Last: | $2.4999 |
---|---|
Change Percent: | -5.96% |
Open: | $2.49 |
Close: | $2.4999 |
High: | $2.54 |
Low: | $2.3101 |
Volume: | 7,384 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.4999 | $2.49 | $2.4999 | $2.54 | $2.3101 | 7,384 | 05-17-2024 |
$2.35 | $2.43 | $2.35 | $2.5 | $2.35 | 11,978 | 05-16-2024 |
$2.49 | $2.59 | $2.49 | $2.6499 | $2.4201 | 12,548 | 05-15-2024 |
$2.45 | $2.62 | $2.45 | $2.62 | $2.39 | 18,445 | 05-14-2024 |
$2.51 | $2.63 | $2.51 | $2.6499 | $2.43 | 5,799 | 05-13-2024 |
$2.52 | $2.66 | $2.52 | $2.7775 | $2.52 | 21,368 | 05-10-2024 |
$2.68 | $2.6364 | $2.68 | $2.7499 | $2.63 | 14,115 | 05-09-2024 |
$2.71 | $2.73 | $2.71 | $2.82 | $2.71 | 5,889 | 05-08-2024 |
$2.66 | $3.13 | $2.66 | $3.13 | $2.65 | 38,600 | 05-07-2024 |
$2.65 | $2.73 | $2.65 | $2.73 | $2.5601 | 6,763 | 05-06-2024 |
$2.677 | $2.552 | $2.677 | $2.8472 | $2.55 | 3,591 | 05-03-2024 |
$2.5987 | $2.52 | $2.5987 | $2.7 | $2.52 | 4,294 | 05-02-2024 |
$2.5615 | $2.6261 | $2.5615 | $2.65 | $2.535 | 2,592 | 05-01-2024 |
$2.55 | $2.698 | $2.55 | $2.75 | $2.55 | 10,521 | 04-30-2024 |
$2.645 | $3.12 | $2.645 | $3.24 | $2.56 | 48,519 | 04-29-2024 |
$2.93 | $2.75 | $2.93 | $3 | $2.5301 | 25,186 | 04-26-2024 |
$2.59 | $2.79 | $2.59 | $2.84 | $2.5101 | 26,337 | 04-25-2024 |
$2.9018 | $2.96 | $2.9018 | $2.9999 | $2.8462 | 10,960 | 04-24-2024 |
$2.94 | $2.7001 | $2.94 | $2.9437 | $2.7001 | 8,303 | 04-23-2024 |
$3 | $2.82 | $3 | $3 | $2.82 | 23,414 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
XORTX Therapeutics Inc. Company Name:
XRTX Stock Symbol:
NASDAQ Market:
CALGARY, Alberta, May 17, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)),...
CALGARY, Alberta, May 17, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive ...
CALGARY, Alberta, April 22, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney d...